Quantification of chemical elements in blood of patients affected by multiple sclerosis

Annali dell'Istituto Superiore di Sanita

Volumn 41, Issue 2, 2005, Pages 213-216

  Forte, Giovanni ^a   Visconti, Andrea ^b   Santucci, Simone ^b   Ghazaryan, Anna ^b   Figà Talamanca, Lorenzo ^b   Cannoni, Stefania ^b   Bocca, Beatrice ^a   Pino, Anna ^a   Violante, Nicola ^a   Alimonti, Alessandro ^a   Salvetti, Marco ^b   Ristori, Giovanni ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Blood; Elements; Multiple sclerosis

Indexed keywords

ALUMINUM; ANTIMONY; BARIUM; BERYLLIUM; BISMUTH; CADMIUM; CALCIUM; CHROMIUM; COBALT; COPPER; IRON; LEAD; LITHIUM; MAGNESIUM; MANGANESE; MERCURY; MOLYBDENUM; NICKEL; SILICON; STRONTIUM; THALLIUM; TIN; TRACE ELEMENT; TUNGSTEN; VANADIUM; ZINC; ZIRCONIUM;

ADULT; ARTICLE; ATOMIC EMISSION SPECTROMETRY; BLOOD LEVEL; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MULTIPLE SCLEROSIS; PATHOGENESIS; QUANTITATIVE ANALYSIS;

ADULT; BIOLOGICAL MARKERS; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; METALS; MIDDLE AGED; MULTIPLE SCLEROSIS; SILICON; SPECIMEN HANDLING; TRACE ELEMENTS;

EID: 31644441324     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Steiman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 1996;85:299-302.
2. Madsen LS, Andersson EC, Jansson L, Krogsgaard M, Andersen CB, Engberg J, Strominger JL, Svejgaard A, Hjorth JP, Holmdahl R, Wucherpfennig KW, Fugger LA. Humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat Genet 1999;23:343-7.
3. Ruse T, Moen BE, Kyvik KR. Organic solvents and the risk of multiple sclerosis. Epidemiology 2002;13(6):718-20.
4. Gronning M, Albrektsen G, Kvale G, Moen B, Aarli JA, Nyland H. Organic solvents and multiple sclerosis: a case-control study. Acta Neurol Scand 1993;88(4):247-50.
5. Schiffer RB, Weitkamp LR, Ford C, Hall WJ. A genetic marker and family history study of the upstate New York multiple sclerosis cluster. Neurology 1994;44:329-33.
6. Purdey M. Chronic barium intoxication disrupts sulphated proteoglycan synthesis: a hypothesis for the origins of multiple sclerosis. Med Hypotheses 2004;62(5):746-54.
7. Zapadniuk BV. The incidence of multiple sclerosis and the content of cobalt, boron, zinc, manganese and molybdenum in the arable soils of different climatic zones of Ukraine. Lik Sprava 1992;1:111-3.
8. Johnson S. The possible role of gradual accumulation of copper, cadmium, lead and iron and gradual depletion of zinc, magnesium, selenium, vitamins B2, B6, D and E and essential fatty acids in multiple sclerosis. Med Hypotheses 2000;55:239-41.
9. Waterman SJ, el-Fawal HA, Snyder CA. Lead alters the immunogenicity of two neural proteins: a potential mechanism for the progression of lead-induced neurotoxicity. Environ Health Perspect 1994;102:1052-6.
10. Siblerud RL, Kienholz E. Evidence that mercury from silver dental fillings may be an etiological factor in multiple sclerosis. Sci Total Environ 1994;141:191-205.
11. Fung YK, Meade AG, Rack EP, Blotcky AJ. Brain mercury in neurodegenerative disorders. J Toxicol Clin Toxicol 1997;35:49-54.
12. Yasui M, Yase Y, Ando K, Adachi K, Mukoyama M, Ohsugi K. Magnesium concentration in brains from multiple sclerosis patients. Acta Neurol Scand 1990;81(3):197-200.
13. Yasui M, Ota K. Experimental and clinical studies on dysregulation of magnesium metabolism and the aetiopathogenesis of multiple sclerosis. Magnes Res 1992;5(4):295-302.
14. Yasui M, Kihira T, Ota K, Mukoyama M, Adachi K, Sasajima K, Iwata S. Zinc concentration in the central nervous system in a case of multiple sclerosis-comparison with other neurological diseases. No To Shinkei 1991;43(10):951-5.
15. Melo TM, Larsen C, White LR, Aasly J, Sjøbakk TE, Flaten TP, Sonnewald U, Syversen T. Manganese, copper, and zinc in cerebrospinal fluid from patients with multiple sclerosis. Biol Trace Elem Res 2003;93(1-3):1-8.
16. Kapaki E, Segditsa J, Papageorgiou C. Zinc, copper and magnesium concentration in serum and CSF of patients with neurological disorders. Acta Neurol Scand 1989;79(5):373-8.
17. Bush AI. Metals and neuroscience. Curr Opinion Chem Biol 2000;4:184-91.
18. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50(1):121-7.
19. Bocca B, Forte G, Petrucci F, Senofonte O, Violante N, Alimonti A. Development of methods for the quantification of essential and toxic elements in human biomonitoring. Ann Ist Super Sanità 2005;41(2):165-70.
20. Offen D, Gilgun-Sherki Y, Barhum Y, Benhar M, Grinberg L, Reich R, Melamed E, Atlas D. A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis. J Neurochem 2004;89(5):1241-51.
21. Herbert V, Shaw S, Jayatilleke E, Stopler-Kasdan T. Most free-radical injury is iron-related: it is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin. Stem Cells 1994;12(3):289-303.
22. Konijn AM. Iron metabolism in inflammation. Baillieres Clin Haematol 1994;7(4):829-49.
23. Vogt BA, Alam J, Croatt AJ, Vercellotti GM, Nath KA. Acquired resistance to acute oxidative stress. Possible role of heme oxygenase and ferritin. Lab Invest 1995;72(4):474-83.
24. LeVine SM. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res 1997;760:298-303.
25. LeVine SM, Lynch SG, Ou CN, Wulser MJ, Tam E, Boo N. Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients. Brain Res 1999;821:511-5.
26. Casetta I, Invernizzi M, Granieri E. Multiple sclerosis and dental amalgam: case-control study in Ferrara, Italy. Neuroepidemiology 2001;20:134-7.
27. Bangsi D, Ghadirian P, Ducic S, Morisset R, Ciccocioppo S, McMullen E, Krewski D. Dental amalgam and multiple sclerosis: a case-control study in Montreal, Canada. Int J Epidemiol 1998;27:667-71.
28. Qian Y, Harris ED, Zheng Y, Tiffany-Castiglioni E. Lead (Pb) targets GRP78, a molecular chaperone, in C6 rat gliomas cells. Toxicol Appl Pharmacol 2000;163(3):260-6.
29. Markovac J, Goldestein GW. Picomolar concentrations of lead stimulate brain protein kinase C. Nature 1988;334(6177):71-3.
30. Johnston MV, Goldestein GW. Selective vulnerability of the developing brain to lead. Curr Opinion Neurol 1998;1(6):689-93.
31. Earl C, Chantry A, Mohammad N, Glynn P. Zinc ions stabilise the association of basic protein with brain myelin membranes. J Neurochem 1988;51:718-24.